VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Six IPOs Priced Today. Here's What the Window Really Looks Like
Value Add VC/Pulse/IPO6 pricings in one day

Six IPOs Priced Today. Here's What the Window Really Looks Like

Six companies priced IPOs on July 20 alone -- from Jersey Mike's $7.9B consumer offering to Csquare's data-center debut -- the clearest evidence yet that 2026's IPO reopening extends well past AI-branded listings.

By the Numbers

6
IPO pricings, July 20
1
Additional pricing, July 21
$21/share
Csquare price
$3.24B
Csquare valuation
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 20, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Six IPO pricings landed on the calendar for July 20, with one more set for July 21, a density of issuance that hasn't been common on any single day in months and suggests underwriters believe investor demand can absorb multiple simultaneous offerings

2

The batch spans categories: Jersey Mike's consumer-brand offering targeting up to $7.94 billion sits alongside smaller, more specialized names, showing this isn't a single-sector rally concentrated in AI or tech

3

Brookfield-backed Csquare, a data center operator, priced its own IPO at $21 per share on July 16 -- below its original $23-27 target range -- and its shares fell in their NYSE debut, a reminder that not every 2026 listing is getting a clean landing even in a hot window

4

Together, a strong headline pricing (Jersey Mike's) and a soft one (Csquare) in the same two-week stretch paint a more complete picture than either data point alone: demand is real, but pricing discipline is back, and investors are differentiating hard between names rather than buying every new listing indiscriminately

TC

The VC Read · Trace's Take

Trace Cohen

Six pricings in one day with a clean winner and a soft loser is the healthiest signal the IPO market has sent all year -- real differentiation beats indiscriminate demand every time, because indiscriminate demand is exactly what blew up the 2021 SPAC cycle. If you're planning a 2027 listing, Csquare's below-range pricing is the more useful data point to study than Jersey Mike's clean one -- it tells you what happens when the story isn't quite tight enough.

Analysis

Six companies priced IPOs on the calendar for July 20 alone, with one more set to price July 21 -- a density of issuance that hasn't been typical on any single trading day in months, and a signal that underwriters believe current investor demand can absorb several simultaneous offerings without any one of them getting squeezed on price.

Here's what's actually confirmed about the batch so far:

  • Jersey Mike's: the headline name, a consumer-brand offering targeting up to a $7.94 billion valuation -- evidence 2026's IPO reopening extends well past the AI-branded mega-listings (SpaceX, and soon potentially Anthropic) that have dominated headlines this year
  • Csquare: Brookfield-backed data center operator, priced at $21/share on July 16 (below its original $23-27 target range) for a $3.24 billion valuation, and its shares fell in their NYSE debut
  • The remaining names in the July 20 cohort were smaller, more specialized listings that haven't drawn the same headline coverage -- itself a sign this is genuine broad-based issuance, not a single marquee deal getting counted six different ways

Read together, a strong pricing (Jersey Mike's, on track for its full range) alongside a soft one (Csquare, priced below range and trading down) in the same two-week window is more informative than either data point in isolation. It suggests genuine investor demand for new issuance exists, but with real pricing discipline and company-by-company differentiation -- a healthier market dynamic than either a universal rally or a closed window, and a better environment for well-positioned companies than the boom-bust IPO cycles of 2021 and 2022.

What to watch: whether the six July 20 pricings collectively trade up or down in their first week, which will tell underwriters whether to keep clustering issuance or space deals out to avoid oversupplying investor demand on any single day.

ShareXLinkedInEmail

More on

Jersey Mike's →Csquare →

Reported by Value Add Pulse Analysis · First reported by Value Add Pulse · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com